logo

RAPT(Delisted)

RAPT Therapeutics·NASDAQ
--
--(--)
5.49 / 10
Netural

Analyst coverage is neutral, with all six analysts issuing Neutral ratings; historical weighted rating is 2.95, slightly below market expectations. Fund flow analysis, however, is excellent (8.03/10). Small, Medium, and Large order flows show positive trends, while block and extra-large flows are negative, indicating institutional caution but retail and mid-size participation. The overall fund flow pattern suggests liquidity support for the stock's upward trend, complementing the bullish technicals and strong fundamentals.

FundamentalSentiment(5.49)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

0%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-20
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate75.0%
Is money flowing into or out of RAPT?
  • RAPT holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.49/10 (Netural).